US-Russia Health Sciences Forum To Facilitate Collaborations

BMI View: Collaborations between pharmaceutical companies, contract research organisations, academia, non-profit organisations and governments will become increasingly important in accelerating research and development. The primary benefit of such partnerships is to spread the risks associated with drug discovery.

To read the full article, please choose one of the following options: